We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRLD icon
3651
World Acceptance Corp
WRLD
$908M
$18K ﹤0.01%
92
+15
+19% +$2.97K
WTI icon
3652
W&T Offshore
WTI
$554M
$18K ﹤0.01%
4,510
-7,934
-64% -$35K
TECX
3653
Tectonic Therapeutic
TECX
$682M
$18K ﹤0.01%
1,139
-1,091
-49% -$22.5K
LGF.B
3654
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$18K ﹤0.01%
1,190
-26,230
-96% -$380K
ZUO
3655
DELISTED
Zuora, Inc.
ZUO
$18K ﹤0.01%
1,174
-532
-31% -$8.2K
ALPN
3656
DELISTED
Alpine Immune Sciences Inc
ALPN
$18K ﹤0.01%
2,004
+1,199
+149% +$10.4K
DOOR
3657
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$18K ﹤0.01%
201
-300
-60% -$29.6K
GMDA
3658
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$18K ﹤0.01%
4,370
-3,894
-47% -$13.1K
THRN
3659
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$18K ﹤0.01%
2,820
+1,928
+216% +$10.4K
ATCO
3660
DELISTED
Atlas Corp.
ATCO
$18K ﹤0.01%
1,223
+1,060
+650% +$15.7K
WEBR
3661
DELISTED
Weber Inc.
WEBR
$18K ﹤0.01%
1,830
+910
+99% +$9.8K
SHAC
3662
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
$18K ﹤0.01%
+1,806
New +$17.6K
TMX
3663
DELISTED
Terminix Global Holdings, Inc.
TMX
$18K ﹤0.01%
391
-1,732
-82% -$74.7K
HMTV
3664
DELISTED
Hemisphere Media Group, Inc.
HMTV
$18K ﹤0.01%
4,052
+2,658
+191% +$16K
TUFN
3665
DELISTED
Tufin Software Technologies Ltd.
TUFN
$18K ﹤0.01%
1,976
+711
+56% +$6.34K
TSC
3666
DELISTED
TriState Capital Holdings, Inc.
TSC
$18K ﹤0.01%
532
+13
+3% +$415
FLOW
3667
DELISTED
SPX FLOW, Inc.
FLOW
$18K ﹤0.01%
206
-456
-69% -$39.1K
SBDS
3668
DELISTED
Solo Brands Inc
SBDS
$18K ﹤0.01%
53
+5
+10% +$2.21K
ADAG
3669
Adagene
ADAG
$244M
$17K ﹤0.01%
4,992
+3,714
+291% +$23.4K
AIR icon
3670
AAR Corp
AIR
$5.85B
$17K ﹤0.01%
341
-2,208
-87% -$95.5K
AKYA
3671
DELISTED
Akoya BioSciences
AKYA
$17K ﹤0.01%
1,604
+498
+45% +$5.78K
AMX icon
3672
America Movil
AMX
$70.3B
$17K ﹤0.01%
825
+109
+15% +$2.1K
BCYC
3673
Bicycle Therapeutics
BCYC
$273M
$17K ﹤0.01%
396
-3,331
-89% -$156K
BOLT icon
3674
Bolt Biotherapeutics
BOLT
$6.44M
$17K ﹤0.01%
304
+89
+41% +$5.99K
CNS icon
3675
Cohen & Steers
CNS
$4.36B
$17K ﹤0.01%
198
-532
-73% -$44.1K

Similar funds

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.